Clinical trial
γδ T Cell Immunotherapy for Treatment of Breast Cancer
NCT03183206 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- γδ T Cell Immunotherapy for Treatment of Breast Cancer
- Lead sponsor
- Fuda Cancer Hospital, Guangzhou
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 15, 2017
- Completion date
- June 15, 2019
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer